Medicare
Americans Paying Billions for Drugs That Don’t Work
Created in 1992 in response to the AIDs crisis, the Food and Drug Administration (FDA) accelerated approval pathway is intended for drugs that address unmet medical needs.
Sepsis Coding Issues Support Enhanced Payment Integrity
OIG recommends continued vigilance and targeted clinical reviews to ensure proper documentation.